How the housing crisis is fuelling a mental health catastrophe
In Sydney the median rent is $700+ a week (30 per cent of median income) and in Perth $600+ (31 per cent). Homeownership is ever more distant, vacancy rates have collapsed, and poorer renters in Melbourne, Adelaide and Brisbane are facing similar gaps between incomes and costs.
This housing stress is now routine. A recent survey found four in five renters spend over 30 per cent of their income on housing. Over three-quarters of renters and mortgage-holders say the crisis has made them fear for their financial security. The toll shows up starkly on our streets and doorsteps. Australia's last census (2021) counted about 122,494 people as homeless on one night: including 7600 rough sleepers, and 23 per cent of those were aged 12 to 24.
Meanwhile, everyday Australians tell similar stories of constant anxiety: pressure to find or keep a home, desperate rental searches, or living out of garages and boarding houses, eroding their sense of dignity. Tenants describe how endless rent hikes and knock-backs made them feel 'less human', always worried about losing any roof over their head.
As housing stress deepens, Australia is also seeing a surge in mental ill-health. Decades of data show young people's psychological distress and diagnosed disorders have soared. For example, analysis of national surveys found the share of 15 to 25-year-olds with high psychological distress more than doubled from 2007 to 2021. The proportion of young Australians reporting a mental disorder in the past year jumped from 26 per cent in 2007 to about 40 per cent by 2022. In 2021–22, three-quarters of 15 to 24-year-olds had at least one chronic condition, with anxiety disorders affecting 26 per cent and depression 17 per cent.
Loading
Suicide and self-harm remain alarmingly high: they are the leading cause of death for young men (among injury deaths) and anxiety disorders the top issue for young women. In short, mental illness is now the single largest health burden facing teens and young adults in Australia.
The pressure on mental health services is immense. GPs provide 85 per cent of mental-health prescriptions, and in 2021–22 people aged 12 to 24 already made up 23 per cent of all Medicare-funded mental health service users.
Sharon Callister, CEO of welfare group Mission Australia, notes that one in five young people report severe distress and more than a fifth rank mental health as their biggest personal challenge. She warns 'so many young people are struggling with stress, anxiety, loneliness and depression', highlighting an 'urgent need for increased mental health support'. Clinics and hotlines are overwhelmed, and long waits for care are the norm, a reality far harsher for those also battling housing insecurity.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Courier-Mail
2 hours ago
- Courier-Mail
Some Aussies will now be eligible for free lung cancer screenings
1/5 From this week, some Aussies with a history of smoking can access free, lifesaving CT scans to detect lung cancer before symptoms appear. Here's what you need to know to see if you're eligible. Australia's first new national cancer screening program in almost two decades kicks off this week. From July 1, Australians with a high risk of developing lung cancer can be screened for the disease free of charge. Lung cancer is the fifth most common cancer and the leading cause of cancer death in Australia. The National Lung Cancer Screening Program (NLCSP) will offer low-dose computed tomography (CT) scans to people aged 50-70 years who smoke or have a history of smoking and who don't have the symptoms or signs of lung cancer.
West Australian
8 hours ago
- West Australian
Calls for Government action to tackle crisis level of drug deaths after Penington Institute findings
A planeload of Australians are dying every month to drug overdoses, a new analysis of fatality statistics has shown, sparking calls for more work from governments to tackle the crisis. A new snapshot by the Penington Institute found while overall numbers of drug-induced deaths fell slightly in 2023, there was a growing share of those over 50 dying from unintentional overdoses. The 2272 Australians killed by an overdose in 2023 marked a 10th consecutive year of more than 2000 deaths — roughly the equivalent of a Boeing 737 once a month — and almost twice the national road toll of 1315. Opioids were the most common drug overdosed on, at 43.9 per cent, while benzodiazepines overtook stimulants as the second-placed drug. The snapshot comes ahead of a full report in August, which last year showed WA had recorded the highest per capita rate of overdoses for more than 10 years. Penington Institute chief executive John Ryan said the figures showed how persistent overdoses were in Australia. 'A decade of losing more than 2000 Australians to overdose annually marks a sombre milestone,' he said. 'Governments need to tackle overdose with the same level of energy and enthusiasm used to reduce alcohol and tobacco harm in Australia. We need a comprehensive national overdose response strategy to end the overdose crisis. 'We already know what works to reduce overdose deaths. 'The data tells us that opioids remain the largest contributor to fatal drug overdoses. One relatively cheap and easy solution is giving potential overdose witnesses wider access to naloxone, a life-saving opioid reversal treatment already proven to save lives.' The alarming figures come as a new study will be released on Wednesday showing Generation Xs — those born between 1962 and 1982 — are more likely to die from methamphetamine use. The study, published in the journal Addiction, found the demographic experienced the highest risk of dying from methamphetamine-related causes, such as overdose and cardiovascular disease. While meth deaths have increased fourfold since the start of the century, the rates among younger users declined. Among the reasons for the broader rise were a stigma around drug use, misinformation and limited access to tailored support services. 'Many people who use drugs are ageing, and the support systems in place are not designed with their needs in mind,' study author Oisin Stronach said. 'These deaths are complex, often involving multiple substances. Yet much of our service sector remains geared toward people using opioids, leaving people who use methamphetamines — particularly older people — underserved.' Burnet Senior Research Fellow Dr Amanda Roxburgh said the societal stigma around methamphetamine use was a clear barrier to accessing care. 'Methamphetamine is arguably the most stigmatised drug in Australia. That stigma not only isolates people but also deters them from seeking help,' Dr Roxburgh said. 'If we want to save lives, we need to ensure equitable access to health services for all people who use drugs — regardless of their age or substance of choice.'
7NEWS
14 hours ago
- 7NEWS
Life-saving breast cancer drug now cheaper thanks to a expansion of the Pharmaceutical Benefits Scheme
A potentially life-saving treatment for early-stage breast cancer will become much more affordable for hundreds of Australians every year, thanks to a major expansion of the Pharmaceutical Benefits Scheme (PBS). The drug Kisqali (ribociclib), which was previously available for advanced cases, is now being subsidised for a broader group of patients, specifically those with early-stage, hormone receptor-positive, HER2-negative, lymph node-positive breast cancer who are at high risk of their cancer returning after surgery. This accounts for approximately 70 per cent of early stage cases. Specialist Oncologist Dr Belinda Yeo has welcomed the development, telling 7NEWS the drug will reduce the risk of the cancer coming back. 'We know when you combine Kisqali with endocrine therapy, more patients will not have the cancer return. 'It's a frustrating situation that patients find themselves in, is that the risk of the cancer coming back is not necessarily different from year two or three to year five or six,' Dr Teo said. Without the subsidy, patients could be facing a bill of more than $140,000 for a course of treatment. Now, they'll pay just a fraction of that cost, saving families tens of thousands of dollars. Federal Health Minister Mark Butler has told 7NEWS: 'For Labor, that is what the PBS is all about. Access to the best available treatment at affordable PBS prices.' For many, it could mean the difference between life and death. The treatment works by blocking proteins that help cancer cells grow - slowing or even stopping disease progression. Breast cancer remains the most common cancer among women in Australia. On average, 58 people are diagnosed with breast cancer every day, and nine die from the disease. A majority of cases are diagnosed at an early stage - where cancer is found in the breast or nearby lymph nodes, but hasn't spread further. While early detection improves survival rates, recurrence remains a serious risk for patients with stage II and III disease. CEO of Breast Cancer Network Australia Kirsten Pilatti says around 20% of all of those diagnosed with breast cancer will be under 50. 'And we do know, unfortunately, there is an increase in the number of young people being diagnosed with breast cancer.' 'This treatment today really will help to make sure that we can reduce the risk wherever possible of their breast cancer coming back, which is our ultimate aim is to get the breast cancer early to make sure that we give all of the treatment possible to really help reduce the risk of their breast cancer returning,' Pilatti told 7NEWS. Beyond the physical toll, recurrence is a lifelong fear for many breast cancer survivors. By increasing access to advanced treatments like Kisqali, the government hopes to reduce not just the risk of relapse, but also the emotional and financial stress that comes with battling breast cancer. Mother of two, Catherine Mclardy was just 38 years-old when she was diagnosed. She recalled the shock to 7NEWS: 'I joked around that my breast was popping out of the bra a little bit, and another mum said: 'Oh, you should go and get that checked'.' 'I got an ultrasound, and then they said, the doctor wants you to have a mammogram while you're here. I said: 'Okay, got the mammogram.' And then they said: 'Look, we don't want you going home. We want you to get another ultrasound while you're here'.' 'I got the news the next day that I had breast cancer.' What followed was a gruelling treatment of surgery, 16 rounds of chemotherapy and 25 rounds of radiation. And while she is cancer free now, Catherine knows the risk of recurrence is high. 'I sort of felt like I almost had the Grim Reaper's hand on my shoulder sometimes just thinking, you know, it's not a matter of if, but when,' she said. Now Catherine has access to Kisqali she tells 7NEWS: 'Feels like I'd won the lottery, because it's so expensive. So to know that people have options when these kinds of medications go on the PBS, it is really like hitting the jackpot.' The updated PBS listing for Kisqali officially takes effect from July 1.
